COMMUNIQUÉS West-GlobeNewswire

EsoBiotec to Present Preclinical Proof-of-Concept Data for Its Off-the-Shelf ENaBL In Vivo Cell Therapy Platform at the 28th Annual Meeting of the American Society of Gene and Cell Therapy
29/04/2025
Poster talk will present safety and efficacy data for ENaBL-T, a lentiviral vector for in vivo engineering of BCMA CAR T cells, which supported the first in vivo BCMA CAR-T cell therapy clinical trial for patients with [...]
Ostarine Mk-2866 SARMs: Ostarine Cycle, Osta 2866 Benefits, Ostarine PCT, Ostarine Mk-2866 Dosage, Osta 2866 Side Effects, What Is Ostarine, Buy, Before and After By CrazyBulk
29/04/2025
New York , April 29, 2025 (GLOBE NEWSWIRE) -- NEW YORK, April 28, 2025: Crazy Bulk OSTA 2866: A Safe Alternative to Ostarine MK 2866 Crazy Bulk OSTA 2866 is a safe and legal substitute for Ostarine MK 2866. We now have [...]
Le TAR-200 en monothérapie de Johnson & Johnson permet d’atteindre un taux élevé de survie sans maladie de plus de 80 pour cent chez les patients atteints de CVNIM à haut risque papillaire et non sensibles au BCG
29/04/2025
Les premiers résultats de l’étude SunRISe-1 (Cohorte 4) indiquent des taux élevés de survie sans maladie pour les tumeurs papillaires de haut grade, ce qui démontre un fort potentiel de préservation de la vessie, 94 [...]
Regeneron Reports First Quarter 2025 Financial and Operating Results
29/04/2025
First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS (a) of $8.22 First quarter 2025 Dupixent ® global net sales (recorded by Sanofi) increased 19% to $3.67 billion versus [...]
Semen & Cum Pills - Best Volume Pills of 2025 (Supplements for Bigger Loads) - By Semanax
29/04/2025
Limassol, Cyprus, April 29, 2025 (GLOBE NEWSWIRE) -- Particularly in the male enhancement pills industry, Semenax Volume Pills are arguably the best rated and most trusted cum pills for men wanting to increase the [...]
L’entreprise de biotechnologie britannique Stablepharma Ltd. lance en première mondiale un essai de Phase I ciblé sur un vaccin thermostable contre le tétanos et la diphtérie
29/04/2025
LONDRES, 29 avr. 2025 (GLOBE NEWSWIRE) -- Après avoir obtenu l’autorisation de la MHRA, l’autorité britannique de réglementation du marché des dispositifs médicaux, Stablepharma Ltd. entre en essai clinique de Phase I [...]
DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa
29/04/2025
Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis Bullosa Medical Research Foundation (EBMRF), and Stanford University. The financing will enable [...]
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
29/04/2025
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux [...]
Statement re Grant of Options and Warrants
29/04/2025
DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of [...]
The Board of Directors of Financière de Tubize appoints Bruno Holthof as new Chair
29/04/2025
The Board of Directors of Financière de Tubize appoints Bruno Holthof as new Chair As Gaëtan Hannecart did not seek renewal of his director’s mandate at the general shareholders meeting held on April 25, 2025, the Board [...]
Le Conseil d'Administration de la Financière de Tubize nomme Bruno Holthof comme Président
29/04/2025
Le Conseil d'Administration de la Financière de Tubize nomme Bruno Holthof comme Président Suite à la décision de Gaëtan Hannecart de ne pas solliciter le renouvellement de son mandat d'administrateur lors de l' [...]
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update
29/04/2025
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update Successful strategic shift towards a focus on inflammatory and fibrotic diseases, in particular on kidney disease [...]
Santhera Publishes Agenda for its Annual General Meeting
29/04/2025
Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, [...]
New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine
29/04/2025
Daridorexant improved sleep maintenance throughout the entire night, including the last quarter, while also improving next-morning sleepiness. Daridorexant improved next-morning sleepiness compared to placebo from as [...]
Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1
29/04/2025
Ad hoc announcement pursuant to Art. 53 LR Net sales grew +15% (cc 1 , +12% USD) with core operating income 1 up +27% (cc, +23% USD) Sales growth driven by continued strong performance from Entresto (+22% cc), Kisqali [...]
Santhera Full Year Results for the Year Ended 31 December 2024
29/04/2025
Transformational year following the successful launch of AGAMREE® Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today announces its full year results for the year ended 31 December 2024. [...]
Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer
29/04/2025
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis [...]
Lumineye Introduces Sublingual Nano-Drop Formula to Help Support Normal Eye Comfort and Clarity
29/04/2025
Sheridan, Wyoming, USA, April 29, 2025 (GLOBE NEWSWIRE) -- Lumineye , a pioneering company in the health and wellness sector, today announced the launch of its new product: The Lumineye Nanodrop. This advanced dietary [...]
Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
29/04/2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of [...]

Pages